Cresco Labs Net Income
| CRLBF Stock | USD 0.97 0.04 3.96% |
As of the 19th of February, Cresco Labs shows the risk adjusted performance of 0.0359, and Mean Deviation of 6.81. Cresco Labs technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for Cresco Labs, which can be compared to its peers. Please confirm Cresco Labs downside deviation, treynor ratio, expected short fall, as well as the relationship between the variance and potential upside to decide if Cresco Labs is priced correctly, providing market reflects its regular price of 0.97 per share. Given that Cresco Labs is a hitting penny stock territory we recommend to closely look at its total risk alpha.
Cresco Labs' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cresco Labs' valuation are provided below:Cresco Labs does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Cresco |
Cresco Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cresco Labs' otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cresco Labs.
| 11/21/2025 |
| 02/19/2026 |
If you would invest 0.00 in Cresco Labs on November 21, 2025 and sell it all today you would earn a total of 0.00 from holding Cresco Labs or generate 0.0% return on investment in Cresco Labs over 90 days. Cresco Labs is related to or competes with Hua Medicine, Knight Therapeutics, Healios KK, Allergy Therapeutics, Avacta Group, Northwest Biotherapeutics, and PureTech Health. Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis produc... More
Cresco Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cresco Labs' otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cresco Labs upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 8.63 | |||
| Information Ratio | 0.03 | |||
| Maximum Drawdown | 120.83 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 12.1 |
Cresco Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Cresco Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cresco Labs' standard deviation. In reality, there are many statistical measures that can use Cresco Labs historical prices to predict the future Cresco Labs' volatility.| Risk Adjusted Performance | 0.0359 | |||
| Jensen Alpha | 0.4334 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.0465 | |||
| Treynor Ratio | 3.86 |
Cresco Labs February 19, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0359 | |||
| Market Risk Adjusted Performance | 3.87 | |||
| Mean Deviation | 6.81 | |||
| Semi Deviation | 7.93 | |||
| Downside Deviation | 8.63 | |||
| Coefficient Of Variation | 2983.87 | |||
| Standard Deviation | 13.35 | |||
| Variance | 178.35 | |||
| Information Ratio | 0.03 | |||
| Jensen Alpha | 0.4334 | |||
| Total Risk Alpha | (0.18) | |||
| Sortino Ratio | 0.0465 | |||
| Treynor Ratio | 3.86 | |||
| Maximum Drawdown | 120.83 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 12.1 | |||
| Downside Variance | 74.47 | |||
| Semi Variance | 62.84 | |||
| Expected Short fall | (9.43) | |||
| Skewness | 3.68 | |||
| Kurtosis | 23.81 |
Cresco Labs Backtested Returns
Cresco Labs is out of control given 3 months investment horizon. Cresco Labs secures Sharpe Ratio (or Efficiency) of 0.0799, which signifies that the company had a 0.0799 % return per unit of standard deviation over the last 3 months. We have analyzed twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.09% are justified by taking the suggested risk. Use Cresco Labs mean deviation of 6.81, and Risk Adjusted Performance of 0.0359 to evaluate company specific risk that cannot be diversified away. Cresco Labs holds a performance score of 6 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 0.11, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cresco Labs' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cresco Labs is expected to be smaller as well. Use Cresco Labs treynor ratio, expected short fall, and the relationship between the jensen alpha and potential upside , to analyze future returns on Cresco Labs.
Auto-correlation | -0.68 |
Very good reverse predictability
Cresco Labs has very good reverse predictability. Overlapping area represents the amount of predictability between Cresco Labs time series from 21st of November 2025 to 5th of January 2026 and 5th of January 2026 to 19th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cresco Labs price movement. The serial correlation of -0.68 indicates that around 68.0% of current Cresco Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.68 | |
| Spearman Rank Test | -0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Cresco Labs reported net income of (319.6 Million). This is 193.65% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 155.97% higher than that of the company.
Cresco Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cresco Labs' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Cresco Labs could also be used in its relative valuation, which is a method of valuing Cresco Labs by comparing valuation metrics of similar companies.Cresco Labs is currently under evaluation in net income category among its peers.
Cresco Fundamentals
| Return On Equity | -0.0635 | |||
| Return On Asset | 0.0399 | |||
| Profit Margin | (0.08) % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 1.29 B | |||
| Shares Outstanding | 280.99 M | |||
| Shares Owned By Insiders | 22.87 % | |||
| Shares Owned By Institutions | 7.22 % | |||
| Price To Book | 0.95 X | |||
| Price To Sales | 0.83 X | |||
| Revenue | 821.68 M | |||
| Gross Profit | 429.79 M | |||
| EBITDA | (159.63 M) | |||
| Net Income | (319.6 M) | |||
| Cash And Equivalents | 130.04 M | |||
| Cash Per Share | 0.43 X | |||
| Total Debt | 465.08 M | |||
| Debt To Equity | 0.88 % | |||
| Current Ratio | 1.31 X | |||
| Book Value Per Share | 2.62 X | |||
| Cash Flow From Operations | 14.49 M | |||
| Earnings Per Share | (1.15) X | |||
| Target Price | 7.04 | |||
| Number Of Employees | 3.3 K | |||
| Beta | 2.25 | |||
| Market Capitalization | 545.97 M | |||
| Total Asset | 1.78 B | |||
| Z Score | 0.6 | |||
| Net Asset | 1.78 B |
About Cresco Labs Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cresco Labs's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cresco Labs using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cresco Labs based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Cresco OTC Stock
Cresco Labs financial ratios help investors to determine whether Cresco OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cresco with respect to the benefits of owning Cresco Labs security.